share_log

JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price Target

Benzinga ·  Jun 5, 2023 08:09

JMP Securities analyst Jason Butler reiterates Precigen (NASDAQ:PGEN) with a Market Outperform and maintains $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment